EGFR and non-small cell lung carcinoma: EGFR G724S is an uncommon mutation that arises after treatment with first EGFR‐TKIs in NSCLC patients, as shown by the very low mutation frequency of 0.43% (five out of 1170) revealed in osimertinib treatment‐naive patients.18